Studies of infective endocarditis in cardiomyoblasts H9c2 cell line

doi:10.15406/icpjl.2017.04.00117

eISSN: 2471-0016

International Clinical Pathology Journal

Mini Review Volume 4 Issue 6

Studies of infective endocarditis in cardiomyoblasts H9c2 cell line

Berenice Fernandez Rojas,¹ Juan Arturo Gomez Mora,¹ Marisol Rosas Martínez,¹ Gutierrez Venegas Gloria¹

Verify Captcha

Regret for the inconvenience: we are taking measures to prevent fraudulent form submissions by extractors and page crawlers. Please type the correct Captcha word to see email ID.

¹Faculty of Dentistry, National Autonomous University of M
¹Faculty of Dentistry, National Autonomous University of Mexico, Mexico

Correspondence: Gutierrez-Venegas Gloria, Faculty of Dentistry, National Autonomas University of Mexico and Laboratory of Biochemistry of the Division of Postgraduate Studies and Research, Faculty of Dentistry, Ciudad Universitaria, 04510 Mexico

Received: January 01, 1971 | Published: June 23, 2017

Citation: Rojas BF, Mora JAG, Martínez MR, et al. Studies of infective endocarditis in cardiomyoblasts H9c2 cell line. Int Clin Pathol J. 2017;4(6):175–176. DOI: 10.15406/icpjl.2017.04.00117

Download PDF

Abstract

Infective endocarditis (IE) is a condition that could possibly be induced by poor oral hygiene. Peptidoglycan (PGN) and lipoteichoic acid (LTA) promote cytokine expression and nitric oxide (NO) production by binding toll-like receptor (TLR)-2, considered the innate immune response initiator. Some studies have indicated that flavonoids possess antioxidant and anti-inflammatory properties. The aim of this review consisted in describe in vitro studies related to PGN and LTA in IE in H9c2 cell line.

Keywords: infective endocarditis, anti-inflammatory properties, flavonoids possess, valve lesions, hemodialysis, heteropolymer, gram positive bacteria, microorganisms, glucosamine, osmolarity, external turgescence

Abbreviations

IE, infective endocarditis; PGN, peptidoglycan; LTA, lipoteichoic acid; NO, nitric oxide; TLR, toll-like receptor; PAMP, pathogen-associated molecular patterns; TNF, tumor necrosis factor; ROS, reactive oxygen species; PG, plus peptidoglycan

Review

Infective endocarditis (IE) is the inflammatory process that triggers infections in different heart locations such as heart valves, septal defects, tendon cords and the endocardium. As main risks factors for IE disease is the presence of chronic vascular accesses and immune system diseases, out of which the bicuspid valve might be the most affected. Although factors such as age, gender and use of intravenous drugs are also relevant, other risks factors include chronic rheumatic heart disease (which now accounts for <10% of cases in industrialized countries), age-related degenerative valve lesions, hemodialysis, and coexisting conditions such as diabetes, human immunodeficiency virus infection, and intravenous drug use. Antibiotic therapy is the most employed means to treat IE. In developed countries found ratio was 3 to 10 cases out of every 100 000 subjects, females were more affected than males.IE is associated with cultures of Gram positive bacteria, including Staphylococcus aureus, Streptococcus bovis and Streptococcus viridians, as well as cultures with Gram negative bacteria, such as Haemophilus, Aggregatibacter, Cardio bacterium, Eikenella and Kingella, out of which, Streptococcus and Staphylococcus are microorganisms most frequently associated in several types of IE;all are present in dental biofilm.¹

Bacteria could be disseminated into the bloodstream by means of poor oral hygiene, tooth extraction procedures and periodontal treatments.² Immune system is activated after recognizing pathogen-associated molecular patterns (PAMPs) present in the cell wall of microorganisms such as LTA and PGN, also known as murein, which is a heteropolymer formed by an alternating sequence of N-acetyl glucosamine and N-acetylmuramic acid crosslinked with a short peptide (β-1,4 bonds).³ PGN forms an elastic mesh that covers the entire surface of the bacteria; it plays a protective role from cellular damage, allowing it to withstand the pressure of external turgescence due to high osmolarity of the cytoplasm conferring bacteria shape.⁴ This component is found in both Gram positive and negative bacteria. On the other hand, LTA is the major component of the cell wall of Gram positive bacteria.^5,6 It is composed of a backbone of repeating glycerophosphate units with D-alanine or N-acetyl glucosamine substituent and a lipophilic anchor.⁷ Recently it has been suggested that LTA possesses inflammatory properties and plays a role in the pathogenesis of septic shock or severe Gram positive induced inflammatory responses against bacterial infection.⁸

Pooja et al.⁹ have indicated that LTA plays an important role in host cell internalization and Cytotoxicity induction of Streptococcus agalactiae through energy-dependent Endocytic process.⁹ In the context of their research, Zheng et al.¹⁰ mimic septic condition in H9c2 cells in the presence of lip polysaccharide (LPS) plus peptidoglycan (PG). Treatment by LPS plus PGN increased injury markers such as creatine kinase, lactate dehydrogenate, interleukin (IL)-6 and tumor necrosis factor (TNF)-α in the culture supernatant, reduced mitochondrial membrane potential, increased reactive oxygen species production and reduced ATP levels, thus indicating that bacteria affects mitochondria inducing mitochondrial dysfunction.¹⁰

Research employing LTA are related to prevention of damage with flavonoids. Flavonoids are secondary metabolites; they are a family of phenolic compounds practically ubiquitous in plants and in various fruits, leaves and seeds.¹¹ Chemically, flavonoids are derivatives of benzo-c-pyrone and are composed of fifteen backbone carbon atoms sharing a common C6-C3-C6 skeleton.¹² They are classified into six different groups, such as chalcones, flavones, flavonols, flavandiols, anthocyanins and proanthocyanins. Actually, flavonoids have commanded great interest due to their beneficial health effects; they present diverse biological properties such as: Anti-inflammatory, antioxidant, anticancer, antibacterial and antiviral agent. Thus the need arises to carry out new research in order to propose new alternative treatments.

Flavonoid apigenin (2-15mM) prevents, in a dose-dependent fashion, damage induced by LTA (15mg/ml) including IkB degradation, NF-kB translocation, MAPK activation, mRNA levels of COX-2 and IL-1b without cytotoxic effects in H9c2 cells, thus indicating that pre-treatment with apigenin could be used in inflammatory diseases and could be used as a therapeutic agent in IE.¹³ Another study has demonstrated pre-treatment with flavonoids kaempherol, apigenin, naringin and epigallocatechin gallate (10mM ) blocked ERK1/2, JNK, p38 activation, NFkB translocation, IkB degradation, iNOS expression and NO production induced by LTA (15mg/ml) obtained from Streptococcus sanguinis. All these effects regulated inflammatory response and additionally all flavonoids did not exhibit cytotoxic effects; therefore they could become suitable agents to prevent IE.⁷ Luteolin and quercetagetin (10mM) prevented ERK, p-38, JNK, AKT activation. Genistein and quercetin reduced its effects induced by ALT (15mM). All flavonoids reduced IL-1b expression and IkBα activation induced by treatment with ALT. The Flavonoids that were employed prevented inflammation and could be used in inflammatory diseases such as IE.¹⁴

Concluding remarks

Treatments with PGN and LTA induce mitochondrial dysfunction in H9c2 cells. It is well known that mitochondria is the major source of reactive oxygen species (ROS), therefore, mitochondrial dysfunction could increase its production inducing catastrophic damage to the cells. However antioxidants as flavonoids could be employed to scavenge ROS and to reduce this damage. Moreover, flavonoids present anti-inflammatory properties without cytotoxic effects in H9c2 cells and do not generate resistance as opposed to antibiotic therapy. However, new research should target whether these compounds could provide the aforementioned benefits in humans and in a not too distant future manufacture oral products with flavonoids for the prevention of IE, cavities, plaque formation and others.